Stock Analysts’ price target changes for Tuesday, July 7th:
Alcoa (NYSE:AA) had its target price reduced by B. Riley Financial, Inc. from $92.00 to $80.00. B. Riley Financial, Inc. currently has a buy rating on the stock.
American Airlines Group (NASDAQ:AAL) had its price target increased by Susquehanna from $16.00 to $25.00. Susquehanna currently has a positive rating on the stock.
Aercap (NYSE:AER) had its target price boosted by Barclays PLC from $164.00 to $179.00. Barclays PLC currently has an overweight rating on the stock.
Aflac (NYSE:AFL) had its target price reduced by Barclays PLC from $99.00 to $98.00. Barclays PLC currently has an underweight rating on the stock.
Affirm (NASDAQ:AFRM) had its target price increased by TD Cowen from $90.00 to $117.00. They currently have a buy rating on the stock.
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target boosted by Truist Financial Corporation from $36.00 to $41.00. They currently have a buy rating on the stock.
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target raised by Bank of America Corporation from $40.00 to $46.00. They currently have a buy rating on the stock.
Allegiant Travel (NASDAQ:ALGT) had its target price increased by Susquehanna from $85.00 to $132.00. The firm currently has a neutral rating on the stock.
Alaska Air Group (NYSE:ALK) had its price target boosted by Susquehanna from $50.00 to $70.00. Susquehanna currently has a positive rating on the stock.
Allstate (NYSE:ALL) had its target price boosted by Barclays PLC from $203.00 to $213.00. The firm currently has an underweight rating on the stock.
Amgen (NASDAQ:AMGN) had its target price boosted by Truist Financial Corporation from $327.00 to $340.00. They currently have a hold rating on the stock.
AON (NYSE:AON) had its price target increased by Barclays PLC from $372.00 to $382.00. The firm currently has an equal weight rating on the stock.
AppLovin (NASDAQ:APP) had its target price boosted by Wells Fargo & Company from $571.00 to $575.00. They currently have an overweight rating on the stock.
ArcBest (NASDAQ:ARCB) had its target price raised by UBS Group AG from $122.00 to $145.00. The firm currently has a neutral rating on the stock.
argenex (NASDAQ:ARGX) had its price target raised by Royal Bank Of Canada from $890.00 to $945.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Ategrity Specialty (NYSE:ASIC) had its price target boosted by Barclays PLC from $26.00 to $28.00. Barclays PLC currently has an overweight rating on the stock.
American Express (NYSE:AXP) had its target price boosted by Barclays PLC from $322.00 to $364.00. Barclays PLC currently has an equal weight rating on the stock.
American Express (NYSE:AXP) had its price target increased by TD Cowen from $330.00 to $338.00. TD Cowen currently has a hold rating on the stock.
American Express (NYSE:AXP) had its price target boosted by UBS Group AG from $340.00 to $386.00. They currently have a neutral rating on the stock.
Bank of America (NYSE:BAC) had its price target raised by UBS Group AG from $63.00 to $68.00. UBS Group AG currently has a buy rating on the stock.
Booz Allen Hamilton (NYSE:BAH) had its target price trimmed by TD Cowen from $85.00 to $70.00. They currently have a hold rating on the stock.
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its target price raised by Royal Bank Of Canada from $13.00 to $14.00. The firm currently has an outperform rating on the stock.
Bread Financial (NYSE:BFH) had its price target increased by TD Cowen from $95.00 to $103.00. The firm currently has a hold rating on the stock.
Bread Financial (NYSE:BFH) had its target price increased by UBS Group AG from $94.00 to $120.00. They currently have a buy rating on the stock.
Bread Financial (NYSE:BFH) had its price target increased by The Goldman Sachs Group, Inc. from $94.00 to $108.00. They currently have a neutral rating on the stock.
The Berkeley Group (LON:BKG) had its price target reduced by Jefferies Financial Group Inc. from GBX 4,531 to GBX 4,517. Jefferies Financial Group Inc. currently has a buy rating on the stock.
BankUnited (NYSE:BKU) had its target price cut by Barclays PLC from $53.00 to $52.00. Barclays PLC currently has an equal weight rating on the stock.
BioMarin Pharmaceutical (NASDAQ:BMRN) had its target price lowered by Royal Bank Of Canada from $66.00 to $62.00. They currently have a sector perform rating on the stock.
Bunzl (LON:BNZL) had its target price boosted by Royal Bank Of Canada from GBX 2,200 to GBX 2,600. They currently have a sector perform rating on the stock.
Bank of Hawaii (NYSE:BOH) had its price target increased by Barclays PLC from $86.00 to $88.00. They currently have an equal weight rating on the stock.
Brown & Brown (NYSE:BRO) had its price target raised by Barclays PLC from $72.00 to $76.00. The firm currently has an equal weight rating on the stock.
Banco Santander Brasil (NYSE:BSBR) had its price target cut by JPMorgan Chase & Co. from $7.00 to $6.50. The firm currently has an overweight rating on the stock.
Citigroup (NYSE:C) had its price target raised by UBS Group AG from $134.00 to $150.00. UBS Group AG currently has a neutral rating on the stock.
Citigroup (NYSE:C) had its price target raised by Bank of America Corporation from $170.00 to $176.00. They currently have a buy rating on the stock.
Credit Acceptance (NASDAQ:CACC) had its target price increased by TD Cowen from $500.00 to $575.00. They currently have a hold rating on the stock.
CACI International (NYSE:CACI) had its price target trimmed by TD Cowen from $625.00 to $550.00. TD Cowen currently has a buy rating on the stock.
Century Aluminum (NASDAQ:CENX) had its target price cut by B. Riley Financial, Inc. from $86.00 to $74.00. B. Riley Financial, Inc. currently has a buy rating on the stock.
CF Industries (NYSE:CF) had its price target lowered by Morgan Stanley from $135.00 to $115.00. They currently have an equal weight rating on the stock.
Citizens Financial Group (NYSE:CFG) had its target price increased by UBS Group AG from $75.00 to $82.00. The firm currently has a buy rating on the stock.
Cullen/Frost Bankers (NYSE:CFR) had its target price boosted by Barclays PLC from $155.00 to $160.00. Barclays PLC currently has an equal weight rating on the stock.
Chord Energy (NASDAQ:CHRD) had its price target cut by Truist Financial Corporation from $185.00 to $170.00. The firm currently has a buy rating on the stock.
Charter Communications (NASDAQ:CHTR) had its target price trimmed by Wells Fargo & Company from $170.00 to $160.00. They currently have an underweight rating on the stock.
Cleveland-Cliffs (NYSE:CLF) had its target price trimmed by Citigroup Inc. from $11.00 to $10.00. Citigroup Inc. currently has a neutral rating on the stock.
Commercial Metals (NYSE:CMC) had its target price lowered by Citigroup Inc. from $85.00 to $75.00. Citigroup Inc. currently has a buy rating on the stock.
Comcast (NASDAQ:CMCSA) had its target price trimmed by Wells Fargo & Company from $29.00 to $28.00. The firm currently has an underweight rating on the stock.
Comcast (NASDAQ:CMCSA) had its target price trimmed by Morgan Stanley from $33.00 to $30.00. The firm currently has an equal weight rating on the stock.
Compass Pathways (NASDAQ:CMPS) had its price target raised by BTIG Research from $14.00 to $25.00. BTIG Research currently has a buy rating on the stock.
Centene (NYSE:CNC) had its price target raised by Cantor Fitzgerald from $60.00 to $75.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Capital One Financial (NYSE:COF) had its target price boosted by UBS Group AG from $270.00 to $275.00. They currently have a buy rating on the stock.
Capital One Financial (NYSE:COF) had its price target lowered by TD Cowen from $260.00 to $253.00. They currently have a buy rating on the stock.
Compass (NYSE:COMP) had its target price increased by Wells Fargo & Company from $9.00 to $12.00. Wells Fargo & Company currently has an equal weight rating on the stock.
ConocoPhillips (NYSE:COP) had its target price reduced by Mizuho from $150.00 to $146.00. Mizuho currently has an outperform rating on the stock.
Corebridge Financial (NYSE:CRBG) had its price target raised by Barclays PLC from $30.00 to $33.00. The firm currently has an overweight rating on the stock.
CorMedix (NASDAQ:CRMD) had its target price cut by Royal Bank Of Canada from $14.00 to $13.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Crinetics Pharmaceuticals (NASDAQ:CRNX) had its target price raised by Robert W. Baird from $62.00 to $85.00. They currently have an outperform rating on the stock.
Carlisle Companies (NYSE:CSL) had its price target reduced by Truist Financial Corporation from $360.00 to $340.00. The firm currently has a hold rating on the stock.
CSX (NASDAQ:CSX) had its target price raised by Robert W. Baird from $49.00 to $53.00. The firm currently has an outperform rating on the stock.
CVR Energy (NYSE:CVI) had its price target reduced by Mizuho from $35.00 to $28.00. The firm currently has an underperform rating on the stock.
CVS Health (NYSE:CVS) had its target price boosted by Cantor Fitzgerald from $100.00 to $110.00. The firm currently has an overweight rating on the stock.
CoreCivic (NYSE:CXW) had its target price raised by Benchmark Co. from $36.00 to $41.00. They currently have a buy rating on the stock.
Delta Air Lines (NYSE:DAL) had its price target raised by Susquehanna from $78.00 to $108.00. They currently have a positive rating on the stock.
Domino’s Pizza (NASDAQ:DPZ) had its price target trimmed by Citigroup Inc. from $365.00 to $335.00. Citigroup Inc. currently has a neutral rating on the stock.
Elevance Health (NYSE:ELV) had its target price boosted by Cantor Fitzgerald from $400.00 to $450.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Enlight Renewable Energy (NASDAQ:ENLT) had its price target reduced by UBS Group AG from $123.00 to $115.00. The firm currently has a buy rating on the stock.
Enova International (NYSE:ENVA) had its price target boosted by TD Cowen from $190.00 to $250.00. TD Cowen currently has a buy rating on the stock.
Edgewell Personal Care (NYSE:EPC) had its price target raised by Canaccord Genuity Group Inc. from $32.00 to $34.00. The firm currently has a buy rating on the stock.
ESAB (NYSE:ESAB) had its price target increased by Roth Capital from $142.00 to $151.00. Roth Capital currently has a buy rating on the stock.
Exelixis (NASDAQ:EXEL) had its target price raised by Truist Financial Corporation from $54.00 to $56.00. Truist Financial Corporation currently has a hold rating on the stock.
FirstCash (NASDAQ:FCFS) had its price target raised by TD Cowen from $235.00 to $240.00. TD Cowen currently has a buy rating on the stock.
First Citizens BancShares (NASDAQ:FCNCA) had its price target raised by The Goldman Sachs Group, Inc. from $2,100.00 to $2,340.00. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
First Hawaiian (NASDAQ:FHB) had its target price boosted by The Goldman Sachs Group, Inc. from $27.00 to $30.00. The Goldman Sachs Group, Inc. currently has a sell rating on the stock.
First Interstate BancSystem (NASDAQ:FIBK) had its target price increased by Barclays PLC from $36.00 to $38.00. Barclays PLC currently has an equal weight rating on the stock.
Fiserv (NASDAQ:FISV) had its price target lowered by TD Cowen from $64.00 to $63.00. The firm currently has a neutral rating on the stock.
Fifth Third Bancorp (NASDAQ:FITB) had its target price boosted by UBS Group AG from $60.00 to $65.00. The firm currently has a buy rating on the stock.
Flagstar Bank, National Association (NYSE:FLG) had its price target boosted by Barclays PLC from $16.00 to $17.00. The firm currently has an overweight rating on the stock.
Genpact (NYSE:G) had its price target trimmed by Robert W. Baird from $45.00 to $38.00. The firm currently has a neutral rating on the stock.
Gilead Sciences (NASDAQ:GILD) had its target price reduced by Truist Financial Corporation from $157.00 to $156.00. They currently have a buy rating on the stock.
Gilead Sciences (NASDAQ:GILD) had its price target trimmed by Royal Bank Of Canada from $122.00 to $120.00. The firm currently has a sector perform rating on the stock.
The Goldman Sachs Group (NYSE:GS) had its target price raised by UBS Group AG from $940.00 to $1,120.00. UBS Group AG currently has a neutral rating on the stock.
The Goldman Sachs Group (NYSE:GS) had its price target boosted by Bank of America Corporation from $1,050.00 to $1,150.00. The firm currently has a buy rating on the stock.
Huntington Bancshares (NASDAQ:HBAN) had its price target increased by UBS Group AG from $21.00 to $22.00. UBS Group AG currently has a buy rating on the stock.
HCA Healthcare (NYSE:HCA) had its target price trimmed by Cantor Fitzgerald from $588.00 to $525.00. The firm currently has an overweight rating on the stock.
HUTCHMED (NASDAQ:HCM) had its target price lowered by Bank of America Corporation from $20.00 to $17.00. The firm currently has a buy rating on the stock.
Honeywell International (NASDAQ:HON) had its price target lowered by JPMorgan Chase & Co. from $260.00 to $250.00. The firm currently has an overweight rating on the stock.
Humana (NYSE:HUM) had its price target boosted by Cantor Fitzgerald from $264.00 to $300.00. Cantor Fitzgerald currently has a neutral rating on the stock.
Intercontinental Exchange (NYSE:ICE) had its price target cut by UBS Group AG from $205.00 to $190.00. UBS Group AG currently has a buy rating on the stock.
IDEAYA Biosciences (NASDAQ:IDYA) had its target price trimmed by Truist Financial Corporation from $65.00 to $63.00. They currently have a buy rating on the stock.
iHeartMedia (NASDAQ:IHRT) had its price target lowered by Bank of America Corporation from $6.00 to $5.00. The firm currently has a neutral rating on the stock.
Itau Unibanco (NYSE:ITUB) had its price target increased by JPMorgan Chase & Co. from $9.00 to $10.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target reduced by Truist Financial Corporation from $256.00 to $254.00. Truist Financial Corporation currently has a buy rating on the stock.
JetBlue Airways (NASDAQ:JBLU) had its price target boosted by Susquehanna from $5.00 to $6.00. They currently have a neutral rating on the stock.
JPMorgan Chase & Co. (NYSE:JPM) had its price target boosted by Bank of America Corporation from $362.00 to $408.00. They currently have a buy rating on the stock.
JPMorgan Chase & Co. (NYSE:JPM) had its price target increased by UBS Group AG from $375.00 to $384.00. They currently have a buy rating on the stock.
KeyCorp (NYSE:KEY) had its price target boosted by UBS Group AG from $25.00 to $27.00. UBS Group AG currently has a buy rating on the stock.
Klarna Group (NYSE:KLAR) had its target price boosted by TD Cowen from $17.00 to $19.00. The firm currently has a hold rating on the stock.
Leidos (NYSE:LDOS) had its target price lowered by TD Cowen from $160.00 to $115.00. The firm currently has a hold rating on the stock.
Largo (NYSE:LGO) had its target price lowered by HC Wainwright from $2.80 to $2.40. HC Wainwright currently has a buy rating on the stock.
Eli Lilly and Company (NYSE:LLY) had its target price increased by JPMorgan Chase & Co. from $1,300.00 to $1,400.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Southwest Airlines (NYSE:LUV) had its price target increased by Susquehanna from $44.00 to $55.00. The firm currently has a neutral rating on the stock.
Mastercard (NYSE:MA) had its price target boosted by Robert W. Baird from $660.00 to $680.00. Robert W. Baird currently has an outperform rating on the stock.
Mastercard (NYSE:MA) had its target price trimmed by TD Cowen from $671.00 to $664.00. The firm currently has a buy rating on the stock.
Moody’s (NYSE:MCO) had its target price increased by Morgan Stanley from $491.00 to $496.00. Morgan Stanley currently has an equal weight rating on the stock.
Moody’s (NYSE:MCO) had its price target boosted by BMO Capital Markets from $489.00 to $515.00. They currently have a market perform rating on the stock.
Magnolia Oil & Gas (NYSE:MGY) had its price target reduced by Truist Financial Corporation from $34.00 to $32.00. Truist Financial Corporation currently has a hold rating on the stock.
Altria Group (NYSE:MO) had its target price boosted by UBS Group AG from $76.00 to $79.00. They currently have a buy rating on the stock.
Morningstar (NASDAQ:MORN) had its target price reduced by UBS Group AG from $280.00 to $260.00. The firm currently has a buy rating on the stock.
Moderna (NASDAQ:MRNA) had its target price raised by Bank of America Corporation from $34.00 to $38.00. Bank of America Corporation currently has an underperform rating on the stock.
Morgan Stanley (NYSE:MS) had its price target increased by Bank of America Corporation from $225.00 to $250.00. They currently have a buy rating on the stock.
Morgan Stanley (NYSE:MS) had its target price increased by UBS Group AG from $214.00 to $255.00. The firm currently has a buy rating on the stock.
Strategy (NASDAQ:MSTR) had its price target reduced by Mizuho from $265.00 to $213.00. The firm currently has an outperform rating on the stock.
M&T Bank (NYSE:MTB) had its target price raised by UBS Group AG from $225.00 to $252.00. The firm currently has a neutral rating on the stock.
Match Group (NASDAQ:MTCH) had its target price raised by Wells Fargo & Company from $38.00 to $41.00. They currently have an equal weight rating on the stock.
Navient (NASDAQ:NAVI) had its target price trimmed by TD Cowen from $9.00 to $8.50. They currently have a sell rating on the stock.
Neurocrine Biosciences (NASDAQ:NBIX) had its target price raised by Royal Bank Of Canada from $183.00 to $195.00. They currently have an outperform rating on the stock.
Nexa Resources (NYSE:NEXA) had its price target increased by Scotiabank from $14.50 to $15.00. The firm currently has a sector perform rating on the stock.
Nutrien (NYSE:NTR) had its target price reduced by Morgan Stanley from $93.00 to $81.00. The firm currently has an overweight rating on the stock.
Northern Trust (NASDAQ:NTRS) had its target price raised by Bank of America Corporation from $190.00 to $200.00. Bank of America Corporation currently has a buy rating on the stock.
NU (NYSE:NU) had its price target raised by JPMorgan Chase & Co. from $18.00 to $20.00. The firm currently has an overweight rating on the stock.
Nuvation Bio (NYSE:NUVB) had its price target boosted by Truist Financial Corporation from $12.00 to $13.00. The firm currently has a buy rating on the stock.
Old Dominion Freight Line (NASDAQ:ODFL) had its target price raised by UBS Group AG from $216.00 to $224.00. They currently have a neutral rating on the stock.
OneMain (NYSE:OMF) had its target price raised by TD Cowen from $66.00 to $68.00. They currently have a buy rating on the stock.
BeOne Medicines (NASDAQ:ONC) had its target price boosted by Truist Financial Corporation from $413.00 to $416.00. The firm currently has a buy rating on the stock.
Ondas (NASDAQ:ONDS) had its price target trimmed by Needham & Company LLC from $23.00 to $19.00. They currently have a buy rating on the stock.
Palo Alto Networks (NASDAQ:PANW) had its target price increased by Needham & Company LLC from $350.00 to $425.00. Needham & Company LLC currently has a buy rating on the stock.
Pinterest (NYSE:PINS) had its target price raised by Wells Fargo & Company from $28.00 to $30.00. Wells Fargo & Company currently has an overweight rating on the stock.
Fidelis Insurance (NYSE:PLGO) had its price target boosted by Barclays PLC from $22.00 to $24.00. Barclays PLC currently has an equal weight rating on the stock.
The PNC Financial Services Group (NYSE:PNC) had its target price increased by UBS Group AG from $263.00 to $288.00. UBS Group AG currently has a buy rating on the stock.
PROG (NYSE:PRG) had its price target raised by TD Cowen from $45.00 to $50.00. They currently have a buy rating on the stock.
Prudential Financial (NYSE:PRU) had its target price raised by Barclays PLC from $90.00 to $92.00. The firm currently has an underweight rating on the stock.
Protagonist Therapeutics (NASDAQ:PTGX) had its price target raised by Truist Financial Corporation from $121.00 to $145.00. The firm currently has a buy rating on the stock.
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its target price increased by Royal Bank Of Canada from $35.00 to $40.00. The firm currently has an outperform rating on the stock.
Reddit (NYSE:RDDT) had its target price increased by Wells Fargo & Company from $176.00 to $187.00. They currently have an equal weight rating on the stock.
Regeneron Pharmaceuticals (NASDAQ:REGN) had its target price reduced by Truist Financial Corporation from $778.00 to $769.00. The firm currently has a buy rating on the stock.
Regeneron Pharmaceuticals (NASDAQ:REGN) had its target price cut by Royal Bank Of Canada from $707.00 to $696.00. They currently have a sector perform rating on the stock.
Regions Financial (NYSE:RF) had its price target raised by UBS Group AG from $29.00 to $33.00. UBS Group AG currently has a neutral rating on the stock.
Rocket Companies (NYSE:RKT) had its target price trimmed by Barclays PLC from $19.00 to $17.00. Barclays PLC currently has an overweight rating on the stock.
RenaissanceRe (NYSE:RNR) had its price target increased by Barclays PLC from $328.00 to $341.00. Barclays PLC currently has an equal weight rating on the stock.
Saia (NASDAQ:SAIA) had its target price raised by UBS Group AG from $493.00 to $527.00. The firm currently has a buy rating on the stock.
Science Applications International (NASDAQ:SAIC) had its target price reduced by TD Cowen from $130.00 to $125.00. They currently have a hold rating on the stock.
Sezzle (NASDAQ:SEZL) had its target price raised by TD Cowen from $108.00 to $165.00. They currently have a hold rating on the stock.
Skyward Specialty Insurance Group (NASDAQ:SKWD) had its target price increased by Piper Sandler from $55.00 to $68.00. The firm currently has an overweight rating on the stock.
SM Energy (NYSE:SM) had its target price reduced by Mizuho from $38.00 to $37.00. They currently have an outperform rating on the stock.
SM Energy (NYSE:SM) had its target price lowered by Stephens from $61.00 to $52.00. Stephens currently has an overweight rating on the stock.
SM Energy (NYSE:SM) had its target price trimmed by Truist Financial Corporation from $39.00 to $37.00. Truist Financial Corporation currently has a buy rating on the stock.
Snap (NYSE:SNAP) had its target price lowered by Wells Fargo & Company from $7.00 to $5.00. The firm currently has an equal weight rating on the stock.
S&P Global (NYSE:SPGI) had its price target boosted by BMO Capital Markets from $495.00 to $505.00. They currently have an outperform rating on the stock.
S&P Global (NYSE:SPGI) had its price target reduced by UBS Group AG from $550.00 to $525.00. They currently have a buy rating on the stock.
S&P Global (NYSE:SPGI) had its target price trimmed by Royal Bank Of Canada from $560.00 to $510.00. Royal Bank Of Canada currently has an outperform rating on the stock.
S&P Global (NYSE:SPGI) had its price target lowered by Morgan Stanley from $557.00 to $525.00. The firm currently has an overweight rating on the stock.
S&P Global (NYSE:SPGI) had its price target cut by Barclays PLC from $565.00 to $555.00. The firm currently has an overweight rating on the stock.
State Street (NYSE:STT) had its price target increased by Bank of America Corporation from $160.00 to $190.00. They currently have a neutral rating on the stock.
Synchrony Financial (NYSE:SYF) had its price target increased by UBS Group AG from $77.00 to $84.00. UBS Group AG currently has a neutral rating on the stock.
Synchrony Financial (NYSE:SYF) had its price target raised by TD Cowen from $89.00 to $90.00. TD Cowen currently has a buy rating on the stock.
AT&T (NYSE:T) had its price target trimmed by Morgan Stanley from $30.00 to $25.00. They currently have an overweight rating on the stock.
The Beauty Tech Group (LON:TBTG) had its target price boosted by Berenberg Bank from GBX 500 to GBX 550. Berenberg Bank currently has a buy rating on the stock.
Teladoc Health (NYSE:TDOC) had its price target raised by Bank of America Corporation from $9.00 to $10.50. Bank of America Corporation currently has a buy rating on the stock.
TFI International (NYSE:TFII) had its price target increased by UBS Group AG from $110.00 to $154.00. UBS Group AG currently has a neutral rating on the stock.
TG Therapeutics (NASDAQ:TGTX) had its price target increased by Bank of America Corporation from $17.00 to $20.00. Bank of America Corporation currently has an underperform rating on the stock.
T-Mobile US (NASDAQ:TMUS) had its target price cut by Morgan Stanley from $260.00 to $230.00. The firm currently has an overweight rating on the stock.
Tesla (NASDAQ:TSLA) had its price target increased by Royal Bank Of Canada from $475.00 to $500.00. They currently have an outperform rating on the stock.
Take-Two Interactive Software (NASDAQ:TTWO) had its target price increased by Wells Fargo & Company from $287.00 to $289.00. They currently have an overweight rating on the stock.
Unity Software (NYSE:U) had its target price boosted by Wells Fargo & Company from $35.00 to $36.00. Wells Fargo & Company currently has an overweight rating on the stock.
United Airlines (NASDAQ:UAL) had its target price boosted by Susquehanna from $135.00 to $172.00. Susquehanna currently has a positive rating on the stock.
Frontier Group (NASDAQ:ULCC) had its target price raised by Susquehanna from $4.50 to $7.00. Susquehanna currently has a neutral rating on the stock.
Unilever (LON:ULVR) had its target price boosted by Jefferies Financial Group Inc. from GBX 3,700 to GBX 3,800. Jefferies Financial Group Inc. currently has an underperform rating on the stock.
Upbound Group (NASDAQ:UPBD) had its price target raised by TD Cowen from $28.00 to $29.00. They currently have a buy rating on the stock.
Upstart (NASDAQ:UPST) had its target price increased by Needham & Company LLC from $37.00 to $40.00. Needham & Company LLC currently has a buy rating on the stock.
U.S. Bancorp (NYSE:USB) had its target price raised by UBS Group AG from $58.00 to $66.00. UBS Group AG currently has a neutral rating on the stock.
United Therapeutics (NASDAQ:UTHR) had its target price boosted by Royal Bank Of Canada from $701.00 to $704.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Valley National Bancorp (NASDAQ:VLY) had its target price increased by Barclays PLC from $14.00 to $15.00. They currently have an equal weight rating on the stock.
Wells Fargo & Company (NYSE:WFC) had its price target cut by UBS Group AG from $105.00 to $104.00. The firm currently has a buy rating on the stock.
Wells Fargo & Company (NYSE:WFC) had its price target increased by Bank of America Corporation from $95.00 to $102.00. They currently have a buy rating on the stock.
Williams-Sonoma (NYSE:WSM) had its price target raised by KeyCorp from $230.00 to $250.00. They currently have an overweight rating on the stock.
Willis Towers Watson Public (NASDAQ:WTW) had its price target cut by Barclays PLC from $322.00 to $303.00. Barclays PLC currently has an equal weight rating on the stock.
TeraWulf (NASDAQ:WULF) had its target price raised by Needham & Company LLC from $28.00 to $33.00. Needham & Company LLC currently has a buy rating on the stock.
TeraWulf (NASDAQ:WULF) had its target price boosted by Rosenblatt Securities from $27.00 to $30.00. They currently have a buy rating on the stock.
Xencor (NASDAQ:XNCR) had its target price lowered by Truist Financial Corporation from $29.00 to $27.00. Truist Financial Corporation currently has a buy rating on the stock.
XPO (NYSE:XPO) had its price target raised by UBS Group AG from $236.00 to $257.00. The firm currently has a buy rating on the stock.
Zillow Group (NASDAQ:ZG) had its target price increased by Wells Fargo & Company from $45.00 to $46.00. The firm currently has an equal weight rating on the stock.
Zymeworks (NASDAQ:ZYME) had its price target boosted by Truist Financial Corporation from $28.00 to $31.00. Truist Financial Corporation currently has a buy rating on the stock.
Receive News & Ratings for Alcoa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcoa and related companies with MarketBeat.com's FREE daily email newsletter.
